Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-Aminopyridine |
---|---|
Date Designated: | 12/14/2005 |
Orphan Designation: | Treatment chronic functional motor and sensory deficits from Guillain-Barre syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley, New York 10502 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-